Augmentation of Meniscal Repair With Marrow Stimulation Techniques (Microfractures)

NCT ID: NCT02323490

Last Updated: 2018-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-08-19

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare meniscal healing augmented or without augmentation with bone marrow stimulation techniques The assessments will include validated, disease specific, patient oriented outcome measures, second look arthroscopy during second step ACL reconstruction. Results of this study will help ascertain whether microfractures improve meniscal healing rates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The role of meniscal in the knee integrity is pivotal and lack or partial role of the meniscus increases rate of joint degeneration. Partial meniscal removal is the most popular procedure and meniscal repair remain in minority of arthroscopic surgeries. As criteria of inclusion to meniscal repair are very rough, still success rates of meniscal repair remain in the 60-80% range for isolated repairs. This rate is greater when performed with ACL reconstruction. We believe that augmentation with bone marrow stimulation techniques will induce more complete and possibly faster healing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meniscus Lesion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

with microfractures

Standardized meniscal repair with bone marrow stimulation techniques (microfractures)

Group Type EXPERIMENTAL

with microfractures

Intervention Type PROCEDURE

following meniscal repair, microfractures will be created on the intercondylar and outer part of femoral condyle (outside of joint surface), lateral or medial, respectively

without microfractures

Standardized meniscal repair without augmentation

Group Type PLACEBO_COMPARATOR

without microfractures

Intervention Type PROCEDURE

standard procedure meniscal repair without augmentation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

with microfractures

following meniscal repair, microfractures will be created on the intercondylar and outer part of femoral condyle (outside of joint surface), lateral or medial, respectively

Intervention Type PROCEDURE

without microfractures

standard procedure meniscal repair without augmentation.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Complete vertical longitudinal tear \> 10 mm in length
* Tear located in the vascular portion of the meniscus, only in red-white zone
* Unstable peripheral tear
* Single tear of the medial and/or lateral meniscus
* Meniscal injury 1 -18 month prior surgery
* Planned second step arthroscopy (ACL reconstruction)
* Skeletally mature patients 18-55 years of age

Exclusion Criteria

* discoid meniscus
* arthritic changes (Kellgren Lawrence scale \>2)
* non repairable meniscus
* degenerative or presence of crystals in meniscus
* concomitant procedure (acl reconstruction, microfracturing, trephination)
* inflammatory diseases (i.e. rheumatoid arthritis)
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre of Postgraduate Medical Education

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rafał Kamiński

M.D. Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rafał Kamiński, M.D. Ph.D.

Role: PRINCIPAL_INVESTIGATOR

SPSK Prof A. Gruca Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Prof. A. Gruca Teaching Hospital, The Medical Centre of Postgraduate Education

Otwock, Woj. Mazowieckie, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

References

Explore related publications, articles, or registry entries linked to this study.

Kaminski R, Kulinski K, Kozar-Kaminska K, Wasko MK, Langner M, Pomianowski S. Repair Augmentation of Unstable, Complete Vertical Meniscal Tears With Bone Marrow Venting Procedure: A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study. Arthroscopy. 2019 May;35(5):1500-1508.e1. doi: 10.1016/j.arthro.2018.11.056. Epub 2019 Mar 20.

Reference Type DERIVED
PMID: 30902532 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

men_micro

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SHould You TransFer the Tubercle?
NCT05759039 RECRUITING NA